Understanding Your Diagnosis: Cystadenofibroma
At a Glance
Cystadenofibroma is a rare benign ovarian tumor made of cysts and fibrous tissue. Because this mixed structure can look complex or suspicious on ultrasound or MRI, a pathologist usually needs to examine tissue to confirm the diagnosis.
Learning that you have a suspected or confirmed cystadenofibroma often begins with a period of intense anxiety. Because these tumors frequently look concerning on ultrasound and MRI scans, many patients are told their mass is “suspicious” or “complex” before surgery [1][2]. Discovering through final pathology that it is actually benign (non-cancerous) can bring immense relief after the fear of a life-altering diagnosis.
What is a Cystadenofibroma?
A cystadenofibroma is a benign ovarian tumor characterized by a unique “biphasic” (two-part) composition [3]. It is made of two distinct types of tissue:
- Epithelial Tissue: This forms fluid-filled sacs or cysts. These are often lined with cells similar to those found in the fallopian tubes or the cervix (Müllerian-type epithelium) [4][5].
- Stromal Tissue: This is a solid, dense, fibrous tissue that acts like the “scaffolding” of the tumor.
While many benign ovarian tumors are either purely fluid-filled (like a simple cyst) or purely solid, a cystadenofibroma mixes both. This combination creates a “complex” appearance on medical imaging that can be very difficult to distinguish from cancer or borderline tumors without a pathologist looking at the actual tissue under a microscope [4][1].
A Rare Finding
Cystadenofibromas are quite rare. Some research estimates they account for less than 2% of all benign ovarian tumors, though figures can vary [6][7]. Because they are uncommon, not every radiologist or general practitioner may see them frequently, which can contribute to the caution they express when first seeing one on a scan.
Why it Raises Concern on Scans
The primary reason these tumors cause so much anxiety is their gross appearance (how they look to the naked eye or on imaging). The dense, fibrous stroma often forms solid lumps or “papillary projections” (finger-like growths) inside the fluid-filled cysts [8].
- Solid Components: On an ultrasound, solid areas in an ovarian mass can raise concern for aggressive cell growth, as cancers often have solid parts. In a cystadenofibroma, these solid areas are just harmless fibrous tissue, but they look concerningly similar on scans [4][1]. (It is important to note that many other benign conditions, like fibromas or endometriomas, can also be solid).
- Complex Architecture: The tumor can have multiple internal compartments (multilocular) and thickened walls, which are additional features that require careful evaluation [1][9].
- The “Shadow” Clue: Sometimes, doctors can find hints that the tumor might be benign. The dense fibrous tissue might create a specific “shadow” on an ultrasound or appear very dark on an MRI, suggesting a fibrous tumor rather than a highly cellular cancer [8][1].
Types of Cystadenofibroma
When examined by a pathologist, these tumors are further classified by the type of fluid and cells they contain:
- Serous: The most common type, often containing thin, watery fluid [10].
- Mucinous: These contain a thicker, jelly-like substance called mucus [10].
- Mixed: A combination of both serous and mucinous elements [10].
Regardless of the type, the defining feature remains the presence of that dense, fibrous stroma [3]. While the initial journey to a diagnosis can be terrifying, a final pathology confirmation of a cystadenofibroma means the growth is benign and does not have the invasive potential of cancer [11].
Common questions in this guide
What is an ovarian cystadenofibroma?
Why can cystadenofibroma look like ovarian cancer on a scan?
How is cystadenofibroma confirmed?
What do serous, mucinous, and mixed cystadenofibroma mean?
Does a cystadenofibroma diagnosis mean I have ovarian cancer?
Will I need follow-up imaging after a cystadenofibroma diagnosis?
Get notified when new evidence is published on cystadenofibroma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Pearls and Potential Pitfalls for Correct Diagnosis of Ovarian Cystadenofibroma in MRI: A Pictorial Essay.
Avesani G, Caliolo G, Gui B, et al.
Korean journal of radiology 2021; (22(11)):1809-1821 doi:10.3348/kjr.2020.1312.
PMID: 34668348 - 2
Benign serous cystadenofibroma with multimodal imaging suggestive of malignancy in a symptomatic postmenopausal patient.
Palisciano M, Terrinoni M, Napoleoni E, et al.
Przeglad menopauzalny = Menopause review 2025; (24(3)):221-224 doi:10.5114/pm.2025.154684.
PMID: 41114411 - 3
A Rare Case of Bilateral Serous Cystadenofibroma in a Malignant Disguise.
Ansari SA, AlSindi K, Aldoseri F
The Gulf journal of oncology 2022; (1(40)):67-70.
PMID: 36448072 - 4
Serous ovarian cystadenofibroma and review of the literature: Report of a case.
Bencherifi Y, Watik F, Lyafi Y, et al.
International journal of surgery case reports 2023; (110()):108649 doi:10.1016/j.ijscr.2023.108649.
PMID: 37639968 - 5
Diagnosis and treatment of a serous cystadenofibroma-like tumor potentially arising from urinary tract endometriosis: A case report.
Horibe Y, Takase R, Kanno T, et al.
Taiwanese journal of obstetrics & gynecology 2025; (64(2)):357-360 doi:10.1016/j.tjog.2024.12.014.
PMID: 40049826 - 6
Omental Serous Cystadenofibroma Mimicking Disseminated Malignancy: A Rare Pathology.
Ezeibe C, Walwyn-Tross L, Perisic D
Journal of medical cases 2026; (17(6)):292-295 doi:10.14740/jmc5316.
PMID: 42146030 - 7
Cystadenofibroma and contralateral collision lesions: A unique ovarian case report.
Kumar N, Rath A, Setty A, et al.
Oncoscience 2025; (12()):26-33 doi:10.18632/oncoscience.616.
PMID: 40165932 - 8
Imaging in gynecological disease (16): clinical and ultrasound characteristics of serous cystadenofibromas in adnexa.
Virgilio BA, De Blasis I, Sladkevicius P, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019; (54(6)):823-830 doi:10.1002/uog.20277.
PMID: 30937992 - 9
A case of ovarian serous cystadenofibroma with scattered lesions in pelvic cavity, like malignant disseminations.
Fujita K, Ogawa C, Sako T, et al.
The journal of obstetrics and gynaecology research 2021; (47(12)):4496-4501 doi:10.1111/jog.15018.
PMID: 34490687 - 10
Ovarian Cystadenofibroma: An Overview.
V V, Samal S
Cureus 2025; (17(7)):e87614 doi:10.7759/cureus.87614.
PMID: 40786313 - 11
MRI of Borderline Epithelial Ovarian Tumors: Pathologic Correlation and Diagnostic Challenges.
Tsuboyama T, Sato K, Ota T, et al.
Radiographics : a review publication of the Radiological Society of North America, Inc 2022; (42(7)):2095-2111 doi:10.1148/rg.220068.
PMID: 36083804
This page explains why cystadenofibroma can look suspicious on imaging and how pathology identifies it as benign. It is for informational purposes only and does not constitute medical advice; discuss your scan, pathology, and follow-up with your healthcare team.